J. Tilch
Allergy. European Journal of Allergy and Clinical Immunology · 2004
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from J. Tilch's perspective
Ordered by how strongly the researchers J. Tilch trusts endorse each paper. Same corpus, a different order for every researcher.
- Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations (Allergy. European Journal of Allergy and Clinical Immunology)
- Delayed Drug Hypersensitivity Reactions (Annals of Internal Medicine)
- General considerations for skin test procedures in the diagnosis of drug hypersensitivity (Allergy. European Journal of Allergy and Clinical Immunology)
- World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis (The World Allergy Organization Journal)
- A new system for grading recommendations in evidence based guidelines (British medical journal)
- HLA-A★3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans (New England Journal of Medicine)
- HLA-B*5701 screening for hypersensitivity to abacavir. (New England Journal of Medicine)
- Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. (New England Journal of Medicine)
- A marker for Stevens–Johnson syndrome
- Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. (Journal of Allergy and Clinical Immunology)
Their papers
- The lymphocyte transformation test in the diagnosis of drug hypersensitivity (2004) — 636 citations